 | • レポートコード：GIR-105X11423 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Chemical & Material |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、メサラミンAPIのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メサラミンAPIの種類別市場規模（純度≥97％、純度≥98％、純度≥99％）、用途別市場規模（メサラミン錠、メサラミンカプセル、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・メサラミンAPIの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Syntese A/S、Divis Laboratories、Cambrex Corporation、Ipca Laboratories、PharmaZell、Lasa Loboratory、Erregierre SpA、Corden Pharma Bergamo、CTX Lifescience、Ishita Active Pharma Ingredients、YC Biotech (Jiangsu)、Xinxiang Tianfeng Fine Chemical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：純度≥97％、純度≥98％、純度≥99％ ・用途別分析2016年-2026年：メサラミン錠、メサラミンカプセル、その他 ・メサラミンAPIの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・メサラミンAPIのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・メサラミンAPIのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・メサラミンAPIの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・メサラミンAPIの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Mesalamine API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Mesalamine API size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Mesalamine API market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Mesalamine API market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Purity ≥ 97 %
Purity ≥ 98 %
Purity ≥ 99 %
Market segment by Application can be divided into
Mesalamine Tablets
Mesalamine Capsules
Others
The key market players for global Mesalamine API market are listed below:
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Mesalamine API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mesalamine API Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Purity ≥ 97 %
1.2.3 Purity ≥ 98 %
1.2.4 Purity ≥ 99 %
1.3 Market Analysis by Application
1.3.1 Overview: Global Mesalamine API Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Mesalamine Tablets
1.3.3 Mesalamine Capsules
1.3.4 Others
1.4 Global Mesalamine API Market Size & Forecast
1.4.1 Global Mesalamine API Sales in Value (2016-2026))
1.4.2 Global Mesalamine API Sales in Volume (2016-2026)
1.4.3 Global Mesalamine API Price by Type (2016-2026) & (USD/Kg)
1.5 Global Mesalamine API Production Capacity Analysis
1.5.1 Global Mesalamine API Total Production Capacity (2016-2026)
1.5.2 Global Mesalamine API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mesalamine API Market Drivers
1.6.2 Mesalamine API Market Restraints
1.6.3 Mesalamine API Trends Analysis
2 Manufacturers Profiles
2.1 Syntese A/S
2.1.1 Syntese A/S Details
2.1.2 Syntese A/S Major Business
2.1.3 Syntese A/S Mesalamine API Product and Services
2.1.4 Syntese A/S Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Divis Laboratories
2.2.1 Divis Laboratories Details
2.2.2 Divis Laboratories Major Business
2.2.3 Divis Laboratories Mesalamine API Product and Services
2.2.4 Divis Laboratories Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Cambrex Corporation
2.3.1 Cambrex Corporation Details
2.3.2 Cambrex Corporation Major Business
2.3.3 Cambrex Corporation Mesalamine API Product and Services
2.3.4 Cambrex Corporation Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Ipca Laboratories
2.4.1 Ipca Laboratories Details
2.4.2 Ipca Laboratories Major Business
2.4.3 Ipca Laboratories Mesalamine API Product and Services
2.4.4 Ipca Laboratories Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 PharmaZell
2.5.1 PharmaZell Details
2.5.2 PharmaZell Major Business
2.5.3 PharmaZell Mesalamine API Product and Services
2.5.4 PharmaZell Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Lasa Loboratory
2.6.1 Lasa Loboratory Details
2.6.2 Lasa Loboratory Major Business
2.6.3 Lasa Loboratory Mesalamine API Product and Services
2.6.4 Lasa Loboratory Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Erregierre SpA
2.7.1 Erregierre SpA Details
2.7.2 Erregierre SpA Major Business
2.7.3 Erregierre SpA Mesalamine API Product and Services
2.7.4 Erregierre SpA Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Corden Pharma Bergamo
2.8.1 Corden Pharma Bergamo Details
2.8.2 Corden Pharma Bergamo Major Business
2.8.3 Corden Pharma Bergamo Mesalamine API Product and Services
2.8.4 Corden Pharma Bergamo Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 CTX Lifescience
2.9.1 CTX Lifescience Details
2.9.2 CTX Lifescience Major Business
2.9.3 CTX Lifescience Mesalamine API Product and Services
2.9.4 CTX Lifescience Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Ishita Active Pharma Ingredients
2.10.1 Ishita Active Pharma Ingredients Details
2.10.2 Ishita Active Pharma Ingredients Major Business
2.10.3 Ishita Active Pharma Ingredients Mesalamine API Product and Services
2.10.4 Ishita Active Pharma Ingredients Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 YC Biotech (Jiangsu)
2.11.1 YC Biotech (Jiangsu) Details
2.11.2 YC Biotech (Jiangsu) Major Business
2.11.3 YC Biotech (Jiangsu) Mesalamine API Product and Services
2.11.4 YC Biotech (Jiangsu) Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Xinxiang Tianfeng Fine Chemical
2.12.1 Xinxiang Tianfeng Fine Chemical Details
2.12.2 Xinxiang Tianfeng Fine Chemical Major Business
2.12.3 Xinxiang Tianfeng Fine Chemical Mesalamine API Product and Services
2.12.4 Xinxiang Tianfeng Fine Chemical Mesalamine API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Mesalamine API Sales by Manufacturer
3.1 Global Mesalamine API Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Mesalamine API Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Mesalamine API
3.4 Market Concentration Rate
3.4.1 Top 3 Mesalamine API Manufacturer Market Share
3.4.2 Top 6 Mesalamine API Manufacturer Market Share
3.5 Global Mesalamine API Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Mesalamine API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mesalamine API Market Size by Region
4.1.1 Global Mesalamine API Sales in Volume by Region (2016-2026)
4.1.2 Global Mesalamine API Revenue by Region (2016-2026)
4.2 North America Mesalamine API Revenue (2016-2026)
4.3 Europe Mesalamine API Revenue (2016-2026)
4.4 Asia-Pacific Mesalamine API Revenue (2016-2026)
4.5 South America Mesalamine API Revenue (2016-2026)
4.6 Middle East and Africa Mesalamine API Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Mesalamine API Sales in Volume by Type (2016-2026)
5.2 Global Mesalamine API Revenue by Type (2016-2026)
5.3 Global Mesalamine API Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Mesalamine API Sales in Volume by Application (2016-2026)
6.2 Global Mesalamine API Revenue by Application (2016-2026)
6.3 Global Mesalamine API Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Mesalamine API Sales by Type (2016-2026)
7.2 North America Mesalamine API Sales by Application (2016-2026)
7.3 North America Mesalamine API Market Size by Country
7.3.1 North America Mesalamine API Sales in Volume by Country (2016-2026)
7.3.2 North America Mesalamine API Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Mesalamine API Sales by Type (2016-2026)
8.2 Europe Mesalamine API Sales by Application (2016-2026)
8.3 Europe Mesalamine API Market Size by Country
8.3.1 Europe Mesalamine API Sales in Volume by Country (2016-2026)
8.3.2 Europe Mesalamine API Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Mesalamine API Sales by Type (2016-2026)
9.2 Asia-Pacific Mesalamine API Sales by Application (2016-2026)
9.3 Asia-Pacific Mesalamine API Market Size by Region
9.3.1 Asia-Pacific Mesalamine API Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Mesalamine API Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Mesalamine API Sales by Type (2016-2026)
10.2 South America Mesalamine API Sales by Application (2016-2026)
10.3 South America Mesalamine API Market Size by Country
10.3.1 South America Mesalamine API Sales in Volume by Country (2016-2026)
10.3.2 South America Mesalamine API Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mesalamine API Sales by Type (2016-2026)
11.2 Middle East & Africa Mesalamine API Sales by Application (2016-2026)
11.3 Middle East & Africa Mesalamine API Market Size by Country
11.3.1 Middle East & Africa Mesalamine API Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Mesalamine API Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Mesalamine API Typical Distributors
12.3 Mesalamine API Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Mesalamine API Revenue by Type, (USD Million), 2021-2026
Table 2. Global Mesalamine API Revenue by Application, (USD Million), 2021-2026
Table 3. Syntese A/S Basic Information, Manufacturing Base and Competitors
Table 4. Syntese A/S Major Business
Table 5. Syntese A/S Mesalamine API Product and Services
Table 6. Syntese A/S Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Divis Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Divis Laboratories Major Business
Table 9. Divis Laboratories Mesalamine API Product and Services
Table 10. Divis Laboratories Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cambrex Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Cambrex Corporation Major Business
Table 13. Cambrex Corporation Mesalamine API Product and Services
Table 14. Cambrex Corporation Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Ipca Laboratories Basic Information, Manufacturing Base and Competitors
Table 16. Ipca Laboratories Major Business
Table 17. Ipca Laboratories Mesalamine API Product and Services
Table 18. Ipca Laboratories Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. PharmaZell Basic Information, Manufacturing Base and Competitors
Table 20. PharmaZell Major Business
Table 21. PharmaZell Mesalamine API Product and Services
Table 22. PharmaZell Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Lasa Loboratory Basic Information, Manufacturing Base and Competitors
Table 24. Lasa Loboratory Major Business
Table 25. Lasa Loboratory Mesalamine API Product and Services
Table 26. Lasa Loboratory Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Erregierre SpA Basic Information, Manufacturing Base and Competitors
Table 28. Erregierre SpA Major Business
Table 29. Erregierre SpA Mesalamine API Product and Services
Table 30. Erregierre SpA Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Corden Pharma Bergamo Basic Information, Manufacturing Base and Competitors
Table 32. Corden Pharma Bergamo Major Business
Table 33. Corden Pharma Bergamo Mesalamine API Product and Services
Table 34. Corden Pharma Bergamo Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. CTX Lifescience Basic Information, Manufacturing Base and Competitors
Table 36. CTX Lifescience Major Business
Table 37. CTX Lifescience Mesalamine API Product and Services
Table 38. CTX Lifescience Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Ishita Active Pharma Ingredients Basic Information, Manufacturing Base and Competitors
Table 40. Ishita Active Pharma Ingredients Major Business
Table 41. Ishita Active Pharma Ingredients Mesalamine API Product and Services
Table 42. Ishita Active Pharma Ingredients Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. YC Biotech (Jiangsu) Basic Information, Manufacturing Base and Competitors
Table 44. YC Biotech (Jiangsu) Major Business
Table 45. YC Biotech (Jiangsu) Mesalamine API Product and Services
Table 46. YC Biotech (Jiangsu) Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Xinxiang Tianfeng Fine Chemical Basic Information, Manufacturing Base and Competitors
Table 48. Xinxiang Tianfeng Fine Chemical Major Business
Table 49. Xinxiang Tianfeng Fine Chemical Mesalamine API Product and Services
Table 50. Xinxiang Tianfeng Fine Chemical Mesalamine API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Mesalamine API Sales by Manufacturer (2019-2021e) & (MT)
Table 52. Global Mesalamine API Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Mesalamine API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Mesalamine API Production Capacity by Company, (MT): 2020 VS 2021
Table 55. Head Office and Mesalamine API Production Site of Key Manufacturer
Table 56. Global Mesalamine API Sales by Region (2016-2021e) & (MT)
Table 57. Global Mesalamine API Sales by Region (2021-2026) & (MT)
Table 58. Global Mesalamine API Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Mesalamine API Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Mesalamine API Sales by Type (2016-2021e) & (MT)
Table 61. Global Mesalamine API Sales by Type (2021-2026) & (MT)
Table 62. Global Mesalamine API Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Mesalamine API Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Mesalamine API Price by Type (2016-2021e) & (USD/Kg)
Table 65. Global Mesalamine API Price by Type (2021-2026) & (USD/Kg)
Table 66. Global Mesalamine API Sales by Application (2016-2021e) & (MT)
Table 67. Global Mesalamine API Sales by Application (2021-2026) & (MT)
Table 68. Global Mesalamine API Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Mesalamine API Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Mesalamine API Price by Application (2016-2021e) & (USD/Kg)
Table 71. Global Mesalamine API Price by Application (2021-2026) & (USD/Kg)
Table 72. North America Mesalamine API Sales by Country (2016-2021e) & (MT)
Table 73. North America Mesalamine API Sales by Country (2021-2026) & (MT)
Table 74. North America Mesalamine API Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Mesalamine API Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Mesalamine API Sales by Type (2016-2021e) & (MT)
Table 77. North America Mesalamine API Sales by Type (2021-2026) & (MT)
Table 78. North America Mesalamine API Sales by Application (2016-2021e) & (MT)
Table 79. North America Mesalamine API Sales by Application (2021-2026) & (MT)
Table 80. Europe Mesalamine API Sales by Country (2016-2021e) & (MT)
Table 81. Europe Mesalamine API Sales by Country (2021-2026) & (MT)
Table 82. Europe Mesalamine API Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Mesalamine API Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Mesalamine API Sales by Type (2016-2021e) & (MT)
Table 85. Europe Mesalamine API Sales by Type (2021-2026) & (MT)
Table 86. Europe Mesalamine API Sales by Application (2016-2021e) & (MT)
Table 87. Europe Mesalamine API Sales by Application (2021-2026) & (MT)
Table 88. Asia-Pacific Mesalamine API Sales by Region (2016-2021e) & (MT)
Table 89. Asia-Pacific Mesalamine API Sales by Region (2021-2026) & (MT)
Table 90. Asia-Pacific Mesalamine API Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Mesalamine API Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Mesalamine API Sales by Type (2016-2021e) & (MT)
Table 93. Asia-Pacific Mesalamine API Sales by Type (2021-2026) & (MT)
Table 94. Asia-Pacific Mesalamine API Sales by Application (2016-2021e) & (MT)
Table 95. Asia-Pacific Mesalamine API Sales by Application (2021-2026) & (MT)
Table 96. South America Mesalamine API Sales by Country (2016-2021e) & (MT)
Table 97. South America Mesalamine API Sales by Country (2021-2026) & (MT)
Table 98. South America Mesalamine API Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Mesalamine API Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Mesalamine API Sales by Type (2016-2021e) & (MT)
Table 101. South America Mesalamine API Sales by Type (2021-2026) & (MT)
Table 102. South America Mesalamine API Sales by Application (2016-2021e) & (MT)
Table 103. South America Mesalamine API Sales by Application (2021-2026) & (MT)
Table 104. Middle East & Africa Mesalamine API Sales by Country (2016-2021e) & (MT)
Table 105. Middle East & Africa Mesalamine API Sales by Country (2021-2026) & (MT)
Table 106. Middle East & Africa Mesalamine API Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Mesalamine API Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Mesalamine API Sales by Type (2016-2021e) & (MT)
Table 109. Middle East & Africa Mesalamine API Sales by Type (2021-2026) & (MT)
Table 110. Middle East & Africa Mesalamine API Sales by Application (2016-2021e) & (MT)
Table 111. Middle East & Africa Mesalamine API Sales by Application (2021-2026) & (MT)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Mesalamine API Typical Distributors
Table 115. Mesalamine API Typical Customers
List of Figures
Figure 1. Mesalamine API Picture
Figure 2. Global Mesalamine API Sales Market Share by Type in 2020
Figure 3. Purity ≥ 97 %
Figure 4. Purity ≥ 98 %
Figure 5. Purity ≥ 99 %
Figure 6. Global Mesalamine API Sales Market Share by Application in 2020
Figure 7. Mesalamine Tablets
Figure 8. Mesalamine Capsules
Figure 9. Others
Figure 10. Global Mesalamine API Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 11. Global Mesalamine API Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Mesalamine API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Mesalamine API Sales (2016-2026) & (MT)
Figure 32. Global Mesalamine API Production Capacity (2016-2026) & (MT)
Figure 33. Global Mesalamine API Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Mesalamine API Market Drivers
Figure 35. Mesalamine API Market Restraints
Figure 36. Mesalamine API Market Trends
Figure 37. Global Mesalamine API Sales Market Share by Manufacturer in 2020
Figure 38. Global Mesalamine API Revenue Market Share by Manufacturer in 2020
Figure 39. Mesalamine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Mesalamine API Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Mesalamine API Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Mesalamine API Sales Market Share by Region (2016-2026)
Figure 43. Global Mesalamine API Revenue Market Share by Region (2016-2026)
Figure 44. North America Mesalamine API Revenue (2016-2026) & (USD Million)
Figure 45. Europe Mesalamine API Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Mesalamine API Revenue (2016-2026) & (USD Million)
Figure 47. South America Mesalamine API Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Mesalamine API Revenue (2016-2026) & (USD Million)
Figure 49. Global Mesalamine API Sales Market Share by Type (2016-2026)
Figure 50. Global Mesalamine API Revenue Market Share by Type (2016-2026)
Figure 51. Global Mesalamine API Price by Type (2016-2026) & (USD/Kg)
Figure 52. Global Mesalamine API Sales Market Share by Application (2016-2026)
Figure 53. Global Mesalamine API Revenue Market Share by Application (2016-2026)
Figure 54. Global Mesalamine API Price by Application (2016-2026) & (USD/Kg)
Figure 55. North America Mesalamine API Sales Market Share by Country (2016-2026)
Figure 56. North America Mesalamine API Revenue Market Share by Country (2016-2026)
Figure 57. North America Mesalamine API Sales Market Share by Type (2016-2026)
Figure 58. North America Mesalamine API Sales Market Share by Application (2016-2026)
Figure 59. Europe Mesalamine API Sales Market Share by Country (2016-2026)
Figure 60. Europe Mesalamine API Revenue Market Share by Country (2016-2026)
Figure 61. Europe Mesalamine API Sales Market Share by Type (2016-2026)
Figure 62. Europe Mesalamine API Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Mesalamine API Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Mesalamine API Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Mesalamine API Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Mesalamine API Sales Market Share by Application (2016-2026)
Figure 67. South America Mesalamine API Sales Market Share by Country (2016-2026)
Figure 68. South America Mesalamine API Revenue Market Share by Country (2016-2026)
Figure 69. South America Mesalamine API Sales Market Share by Type (2016-2026)
Figure 70. South America Mesalamine API Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Mesalamine API Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Mesalamine API Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Mesalamine API Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Mesalamine API Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の高純度テルル化銀市場 2021：企業別、地域別、種類・用途別 The High Purity Silver Telluride market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 世界の高純度AHCL市場 2021：企業別、地域別、種類・用途別 The High Purity AHCL market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の高純度アンチモン化亜鉛市場 2021：企業別、地域別、種類・用途別 The High Purity Zinc Antimonide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の高純度リード市場 2021：企業別、地域別、種類・用途別 The High-Purity Leads market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界の高純度ビスマス市場 2021：企業別、地域別、種類・用途別 The High-Purity Bismuths market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…